Fan, Y., Tao, T., Guo, Z., To, K. K. W., Chen, D., Wu, S., . . . Fu, L. (2022, March). Lazertinib improves the efficacy of chemotherapeutic drugs in ABCB1 or ABCG2 overexpression cancer cells in vitro, in vivo, and ex vivo. Molecular Therapy: Oncolytics.
Chicago Style (17th ed.) CitationFan, Yingfang, et al. "Lazertinib Improves the Efficacy of Chemotherapeutic Drugs in ABCB1 or ABCG2 Overexpression Cancer Cells in Vitro, In vivo, and Ex vivo." Molecular Therapy: Oncolytics Mar. 2022.
MLA (9th ed.) CitationFan, Yingfang, et al. "Lazertinib Improves the Efficacy of Chemotherapeutic Drugs in ABCB1 or ABCG2 Overexpression Cancer Cells in Vitro, In vivo, and Ex vivo." Molecular Therapy: Oncolytics, Mar. 2022.
Warning: These citations may not always be 100% accurate.